Showing results (461-470 of 1,998) with videos related to

Sort By:
Pageof 200
Endocrine, Metabolic & Immune Disorders Drug Targets|June 24, 2026
Lingual Thyroid: Diagnostic and Therapeutic Insights. A Case ReportLingling Song, Jing Yang, Huangruici Zhang, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|January 5, 2024
The Application of Artificial Intelligence in Thyroid Nodules: A Systematic Review Based on Bibliometric AnalysisYun Peng, Tong-Tong Wang, Jing-Zhi Wang, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|July 3, 2026
Mendelian Randomization Analysis of the Inflammatory Factor CXCL5 and Type 2 Diabetes MellitusJiaxin Li, Xing Li, Yuan Li, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|February 2, 2022
A 3-Year-Old Boy with an Xp21 Deletion Syndrome: A Case ReportShaghayegh Sadeghmousavi, Sepideh Shahkarami, Elham Rayzan, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|July 13, 2026
Medication De-escalation in Type 2 Diabetes: A Review of Evidence-Based Strategies for Combination Therapy ReductionOmar Oraibi
Endocrine, Metabolic & Immune Disorders Drug Targets|July 14, 2026
Genetically Predicted 12,13-DiHOME Mediates the Association between TNF-Related Apoptosis-Inducing Ligand and Immune ThrombocytopeniaChendong Jiang, Yiwen Chen, Jun Liang, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|April 20, 2026
Mechanism of Gut Microbiota Dysbiosis in Insulin Resistance Polycystic Ovary SyndromeFatimah Usman, Masagus Irsan Saleh, Kemas Yusuf Effendi, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|April 1, 2026
Andrographolide Attenuates Sepsis-Induced Acute Lung Injury via Peroxisome Proliferator-Activated Receptor Gamma in a Murine Cecal Ligation and Puncture ModelLokesh V Thimmana, Hari Prakash Kalla, Kumarla Kaluva Ruhinaz, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|April 13, 2026
Lactylation-Related Gene Signatures in Intracerebral Hemorrhage: Immune Infiltration, Machine Learning Biomarkers, and Molecular Pathway InsightsYaqun Li, Ju Gao, Yinggang Xiao, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|April 13, 2026
The Key Genus of Gut Microbiota in Cognition Improvement Following Metformin Treatment in T2DM: A Two-sample Mendelian Randomization Study Combined 16s Rrna SequencingYuan Si, Yan Hu, Yile Zhou, et al.
Pageof 200